Wells Fargo & Company Cuts Mettler-Toledo International (NYSE:MTD) Price Target to $1,350.00

Mettler-Toledo International (NYSE:MTD) had its price objective trimmed by Wells Fargo & Company from $1,400.00 to $1,350.00 in a research note published on Monday,Benzinga reports. The firm currently has an equal weight rating on the medical instruments supplier’s stock.

MTD has been the subject of a number of other research reports. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday. JPMorgan Chase & Co. lifted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Stifel Nicolaus increased their price target on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a research note on Monday, August 5th. Finally, Evercore ISI boosted their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $1,338.75.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,239.13 on Monday. The stock has a market cap of $26.15 billion, a PE ratio of 33.41, a price-to-earnings-growth ratio of 4.16 and a beta of 1.16. The stock has a 50-day moving average of $1,388.91 and a 200-day moving average of $1,401.80. Mettler-Toledo International has a one year low of $1,039.01 and a one year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, research analysts anticipate that Mettler-Toledo International will post 40.37 earnings per share for the current year.

Insider Activity

In other news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at $314,820. The trade was a 24.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.94% of the company’s stock.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently made changes to their positions in the stock. Family Firm Inc. acquired a new position in shares of Mettler-Toledo International during the second quarter worth approximately $25,000. Blue Trust Inc. lifted its holdings in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in Mettler-Toledo International in the 3rd quarter valued at $37,000. Rothschild Investment LLC bought a new position in Mettler-Toledo International during the 2nd quarter valued at $42,000. Finally, Itau Unibanco Holding S.A. purchased a new position in Mettler-Toledo International during the second quarter worth about $42,000. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.